Tumors of the Central Nervous System: Clinical Aspects, Molecular Mechanisms, Unanswered Questions, and Future Research Directions

• Published in: Journal of child neurology 2008-10, Vol.23 (10), p.1103-1121
• Main Authors: Babcock, Michael A., Kostova, Felina V., Guha, Abhijit, Packer, Roger J., Pollack, Ian F., Maria, Bernard L.
• Format: Article
• Language: English
• Subjects: Biomedical Research - trends; Central Nervous System Neoplasms - diagnosis; Central Nervous System Neoplasms - physiopathology; Central Nervous System Neoplasms - therapy; Child; Diagnostic Imaging - trends; Drug Therapy - trends; Humans; Molecular Biology - trends; Molecular Diagnostic Techniques - trends; Radiotherapy - trends; Survival Rate - trends
• ISSN: 0883-0738; 1708-8283
• DOI: 10.1177/0883073808321767

Central nervous system tumors are the most common solid tumors in children. Many histological subtypes and biological variants exist. The 2007 Neurobiology of Disease in Children Symposium, held in conjunction with the 36th annual meeting of the Child Neurology Society, aimed to define current knowledge in the field and to develop specific aims for future clinical, translational, and fundamental science. Because of advances in structural and metabolic imaging, surgical technique, and combination therapies, the life expectancy of children with some of the most common tumors, such as cerebellar astrocytomas and medulloblastomas, has improved. Other common tumor types, including diffuse pontine gliomas and malignant embryonal tumors, still have a dismal prognosis. As novel therapies are identified for pediatric central nervous system tumors, long-term survival may be associated with considerable disability. A cooperative effort is crucial to early diagnosis and to translating basic research findings into safe, effective new treatments.